Arthritis, Musculoskeletal and Skin Diseases Research in Missouri
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $79.6 million to recipients in Missouri in 102 grants from fiscal 2021 to 2025, 3.0% of the program's national total. The Washington University received the most, $72.4 million.
- Awarded in Missouri$79.6 million
- Awards102
- Share of the program3.0%
- Rank among states12th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 41 | $12.8 million |
| FY 2022 | 50 | $14.7 million |
| FY 2023 | 53 | $17.0 million |
| FY 2024 | 54 | $19.2 million |
| FY 2025 | 42 | $16.1 million |
Recipients in Missouri
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Washington University | Colleges and universities | 88 | $72.4 million |
| University of Missouri System | Colleges and universities | 6 | $2.4 million |
| Saint Louis University | Colleges and universities | 2 | $2.2 million |
| The Curators of the University of Missouri | Colleges and universities | 3 | $1.8 million |
| G5 Biological Innovations LLC | Small businesses | 1 | $328,984 |
| Apt Therapeutics, Inc. | Small businesses | 1 | $259,576 |
| Stoecker William V MD | Small businesses | 1 | $188,887 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Missouri?
$79.6 million from fiscal 2021 to 2025, across 102 awards. Missouri ranks 12th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Missouri?
The largest recipient is The Washington University, with $72.4 million in 88 awards. Next are University of Missouri System and Saint Louis University.
Can organizations in Missouri apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Missouri
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Broadband Equity, Access, and Deployment Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families